$14.87
-0.110 (-0.734%)
At Close: Jun 03, 2026
Why Bausch + Lomb Stock Soared by Over 7% on Monday
06:40pm, Monday, 14'th Oct 2024
It was quite a busy and eventful day for the company.
Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid
12:20pm, Monday, 14'th Oct 2024
Bausch + Lomb Corporation (BLCO) shares popped Monday morning following reports Blackstone (BX) and TPG (TPG) are considering teaming up to buy the eyecare company.
This week, the Federal Reserve's decision to reduce interest rates by 50 basis points boosted share prices across the technology, construction, industrial, machinery, and financial sectors.
Bausch + Lomb (BLCO) Surges 14.5%: Is This an Indication of Further Gains?
05:16am, Tuesday, 17'th Sep 2024
Bausch + Lomb (BLCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t
Why Bausch + Lomb Rallied Today
03:31pm, Monday, 16'th Sep 2024
The Financial Times reported Bausch + Lomb is in talks with advisors to potentially sell itself. It had formerly sought to spin off from parent Bausch Health in a stock-for-stock deal.
Bausch + Lomb Stock Jumps Amid Reports Of A Sale
01:16pm, Monday, 16'th Sep 2024
Bausch + Lomb (BLCO) shares popped Monday following a report that the eyecare company is considering a sale.
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
11:38am, Monday, 16'th Sep 2024
Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.
Bausch & Lomb reportedly exploring sale, shares rise
10:40am, Monday, 16'th Sep 2024
Bausch & Lomb stock surged on reports the American-Canadian eye health products firm is exploring a sale as it seeks to resolve issues related to its separation from its debt-laden parent company Baus
Bausch + Lomb Corporation (BLCO) Q2 2024 Earnings Call Transcript
04:42pm, Wednesday, 31'st Jul 2024
Bausch + Lomb Corporation (NYSE:BLCO ) Q2 2024 Earnings Call July 31, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President, Investor Relations Brent Saunders - Chairman and Chief Exe
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say
10:36am, Wednesday, 31'st Jul 2024
While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics comp
Bausch + Lomb (BLCO) Matches Q2 Earnings Estimates
09:21am, Wednesday, 31'st Jul 2024
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.13 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.18 per share a year ago.
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
11:07am, Wednesday, 24'th Jul 2024
Bausch + Lomb (BLCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
07:00am, Monday, 17'th Jun 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
07:00am, Monday, 10'th Jun 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. intro
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
07:00am, Monday, 03'rd Jun 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc
Sign In
Buy BLCO